BIT 0.00% 1.9¢ biotron limited

Ann: Lead Series for SARS-COV-2 Program, page-90

  1. 3,582 Posts.
    lightbulb Created with Sketch. 330
    No need to get angry and I agree with you, opposing views are good.
    Quoting MMs words exactly - "The antiviral activity shown across a range of different assays by these three novel compounds against SARS - CoV - 2 is encouraging".
    No wonder the ASX News was marked NOT price sensitive.
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.